Sarah J. Ross - Concepedia

Author

Sarah J. Ross

Also Known As

Mackenzie Ross, S.J., S J Ross, S Ross, S. J. Ross, S. Ross, S.J. Mackenzie Ross, S.J. Ross, Sarah J Ross, Sarah J. Mackenzie Ross, Sarah J. Ross

163

Publications

5.9K

Citations

H-Index

104

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)Newcastle University University of Edinburgh University College London

About

Sarah J. Ross is an author at AstraZeneca (United Kingdom) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	680
2	Business	2	2	106
3	Education	2	2	95
4	Engineering	2	2	2K
5	Management	2	2	95

Sarah J. Ross

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Assessing dissimilarity relations under missing data conditions: Evidence from computer simulations. Natalie J. Allen, David Stanley, Helen Williams, Journal of Applied Psychology EngineeringDissimilarity RelationsGroup PhenomenonSocial PsychologySocial Influence	2007	2K
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models Catherine A. Eberlein, Daniel Stetson, Aleksandra Markovets, Cancer Research	2015	293
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Martin Dennis, Gillian Mead, John Forbes, The Lancet	2018	276
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock, The Lancet	2019	188
Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. Sarah J. Ross, N. L. Graham, L Stuart-Green, Journal of Neurology Neurosurgery & Psychiatry	1996	179
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton, The Lancet	2017	176
Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS Sarah J. Ross, Alexey S. Revenko, Lyndsey Hanson, Science Translational Medicine	2017	175
Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides Sarah J. Ross Open Research Online (The Open University)	2010	162
Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription Sarah J. Ross, Edwin Cheung, Thodoris G. Petrakis, The EMBO Journal Histone ModificationsChromatinTranscriptional RegulationChromatin RemodelingNatural Sciences	2006	157
Ybp1 Is Required for the Hydrogen Peroxide-induced Oxidation of the Yap1 Transcription Factor Elizabeth A. Veal, Sarah J. Ross, Panagiota Malakasi, Journal of Biological Chemistry	2003	151

Page 1